Canadian researchers sign MOU with medical marijuana company

July 7, 2014

Canadian medical-marijuana growing company Tweed Marijuana Inc has signed an MOU with Ryerson University and the University of Ottawa to address the lack of concrete research into the benefits and long-term impacts of medical marijuana use. “With the new [Canadian medical marijuana] regulatory system in place, producers and researchers now have the stability to undertake research not possible in the past,” said Tweed CEO Chuck Rifici. Tweed will work with researchers at Ryerson to determine what affects the quality of medical marijuana, and with researchers at uOttawa to determine active ingredients in medical marijuana and how different strains affect different ailments. “There is an exceptional opportunity to really start to understand the complex effects of active ingredients in marijuana,” said uOttawa professor John Arnason. Ottawa Citizen